[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer

For the positron emission tomography (PET) imaging of prostate cancer, radiotracers targeting the prostate-specific membrane antigen (PSMA) are nowadays used in clinical practice. Almost 10 years after its discovery, [(68)Ga]Ga-PSMA-11 has been approved in the United States by the Food and Drug Admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennrich, Ute, Eder, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401928/
https://www.ncbi.nlm.nih.gov/pubmed/34451810
http://dx.doi.org/10.3390/ph14080713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401928/
https://www.ncbi.nlm.nih.gov/pubmed/34451810
http://dx.doi.org/10.3390/ph14080713

Ejemplares similares